CC BY 4.0 · Endoscopy 2024; 56(S 01): E582-E583
DOI: 10.1055/a-2346-4577
E-Videos

Successful prevention of balloon dilatation after complete circumferential endoscopic submucosal dissection including long-segment Barrett’s esophagus

1   Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
,
1   Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
,
Keisuke Matsusaka
2   Department of Pathology, Chiba University, Chiba, Japan (Ringgold ID: RIN12737)
,
Yuki Ohta
1   Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
,
Takashi Taida
1   Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
3   Endoscopy Center, Chiba University Hospital, Chiba, China (Ringgold ID: RIN92154)
,
Jun Kato
1   Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
3   Endoscopy Center, Chiba University Hospital, Chiba, China (Ringgold ID: RIN92154)
,
Naoya Kato
1   Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
› Author Affiliations
 

Triamcinolone acetonide (TA) injection into submucosa is useful for prevention of stricture after esophageal endoscopic submucosal dissection (ESD) [11]. However, despite attempts with steroid use, complete circumferential esophageal ESD still leads to high stricture rates (36.4% to 85.7% [22] [33] [44]). Although endoscopic balloon dilatation (EBD) is often necessary for stricture relief, it carries the risk of perforation [22]. In addition, in long-segment Barrett’s esophagus (BE) with Barrett's esophageal adenocarcinoma (BEA), post-ESD ulcers can be too long, making EBD challenging. Thus, alternative stricture methods preventing EBD are needed.

Here we present a case of successful prevention of EBD after a circumferential ESD for BEA in long-segment BE (longitudinal length of resected area was 12 cm endoscopically) with intensive TA injections ([Video 1Video 1]). ESD utilized MucoUp (Seikagaku, Tokyo, Japan and Boston Scientific Japan, Kanagawa, Japan) with indigo carmine, 1.5-mm DualKnife J (Olympus Medical Systems, Tokyo, Japan), and the clip-and-line method [55]. En bloc resection, including the entire long-segment BE (Prague classification C8M9), was performed ([Fig. 1Fig. 1]). The pathological finding was BEA with unclear horizontal margin and negative vertical margin ([Fig. 2Fig. 2]).

Weekly intensive triamcinolone acetonide injections were beneficial for preventing stricture in complete circumferential esophageal endoscopic submucosal dissection.Video 1Video 1

Zoom Image
Fig. 1 Fig. 1 The details of endoscopic submucosal dissection (ESD). a The patient was diagnosed with circumferential Barrett's adenocarcinoma with long-segment Barrett’s esophagus (BE) (C8M9 according to the Prague classification). The yellow arrows indicate the proximal boundary of long-segment BE. b ESD was performed with the clip-and-line method. c ESD was performed by creating a submucosal tunnel. The yellow arrows indicate the edge of the submucosal tunnel. d Immediately after ESD, en bloc resection was performed including the entire long-segment BE. The longitudinal length of the post-ESD defect measured endoscopically was up to 12 cm from the oral to the anal side. e A total of 100 mg of triamcinolone acetonide (TA) was locally injected into the remaining submucosa.
Zoom Image
Fig. 2 Fig. 2 Pathological findings of the resected specimen. Histological photograph of an adenocarcinoma at the esophagogastric junction. Atypical glandular epithelium forms irregular tubules, creating polypoid, protruding lesions. Immunostaining shows a mutant pattern of p53 overaccumulation. Meanwhile, a flatly spreading adenocarcinoma is observed around the protrusions. Submucosal esophageal glands in the columnar epithelium region are identified, suggesting an adenocarcinoma arising in Barrett's esophagus.

TA (KENACOLT-A 50 mg/5 mL; Bristol Myers Squibb, Tokyo, Japan) was diluted to 5 mg/mL with normal saline. A 26-gauge 4-mm needle (SG-A 26G FE 4 mm 2200 mm; TOP Corporation, Tokyo, Japan) was used for injection. TA injection into the submucosa, starting immediately post-ESD, was performed at intervals of 0.5 mL (TA 2.5 mg), preventing injury to the muscularis propria. Subsequent injections occurred 3 days post-ESD and then weekly for 21 weeks, with additional injections on weeks 23 and 25, totaling 25 sessions. A total of 50–100 mg TA was administered in each session. At 40 weeks post-ESD, complete epithelialization without stricture was achieved ([Fig. 3Fig. 3]).

Zoom Image
Fig. 3 Fig. 3 The healing process of the post-ESD ulcer. The epithelialization progressed in chronological order from [Fig. 3Fig. 3] a–f. A total of 50 mg or 100 mg of TA was locally injected into the regenerating submucosal layer from [Fig. 3Fig. 3] a–e, respectively. a 1 week after ESD (3rd local injection of TA). b 4 weeks after ESD (6th local injection of TA). c 8 weeks after ESD (10th local injection of TA). d 12 weeks after ESD (14th local injection of TA). e 20 weeks after ESD (22nd local injection of TA). f 40 weeks after ESD. Complete epithelialization without any stricture was achieved, and a φ9.8-mm scope (GIF-H290T; Olympus Medical Systems, Tokyo, Japan) passed easily.

Weekly intensive TA injections alone were beneficial for preventing stricture in complete circumferential esophageal ESD even if the resected area was long.

Endoscopy_UCTN_Code_TTT_1AO_2AO

E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.


#

Conflict of Interest

The authors declare that they have no conflict of interest.

  • References

  • 1 Hashimoto S, Kobayashi M, Takeuchi M. et al. The efficacy of endoscopic triamcinolone injection for the prevention. Gastrointest Endosc 2011; 74: 1389-1393
  • 2 Iizuka T, Kikuchi D, Hoteya S. et al. Effectiveness of modified oral steroid administration for preventing esophageal stricture after entire circumferential endoscopic submucosal dissection. Dis Esophagus 2018; 31
  • 3 Kadota T, Yoda Y, Hori K. et al. Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD). Esophagus 2020; 17: 440-447
  • 4 Minamide T, Kawata N, Maeda Y. et al. Clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma. Gastrointest Endosc 2023; 97: 232-240
  • 5 Oyama T. Counter traction makes endoscopic submucosal dissection easier. Clin Endosc 2012; 45: 375-378

Correspondence

Kenichiro Okimoto, MD
Department of Gastroenterology, Graduate School of Medicine, Chiba University
Inohana 1-8-1
Chiba City, 260-8670
Japan   

Publication History

Article published online:
03 July 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Hashimoto S, Kobayashi M, Takeuchi M. et al. The efficacy of endoscopic triamcinolone injection for the prevention. Gastrointest Endosc 2011; 74: 1389-1393
  • 2 Iizuka T, Kikuchi D, Hoteya S. et al. Effectiveness of modified oral steroid administration for preventing esophageal stricture after entire circumferential endoscopic submucosal dissection. Dis Esophagus 2018; 31
  • 3 Kadota T, Yoda Y, Hori K. et al. Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD). Esophagus 2020; 17: 440-447
  • 4 Minamide T, Kawata N, Maeda Y. et al. Clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma. Gastrointest Endosc 2023; 97: 232-240
  • 5 Oyama T. Counter traction makes endoscopic submucosal dissection easier. Clin Endosc 2012; 45: 375-378

Zoom Image
Fig. 1 Fig. 1 The details of endoscopic submucosal dissection (ESD). a The patient was diagnosed with circumferential Barrett's adenocarcinoma with long-segment Barrett’s esophagus (BE) (C8M9 according to the Prague classification). The yellow arrows indicate the proximal boundary of long-segment BE. b ESD was performed with the clip-and-line method. c ESD was performed by creating a submucosal tunnel. The yellow arrows indicate the edge of the submucosal tunnel. d Immediately after ESD, en bloc resection was performed including the entire long-segment BE. The longitudinal length of the post-ESD defect measured endoscopically was up to 12 cm from the oral to the anal side. e A total of 100 mg of triamcinolone acetonide (TA) was locally injected into the remaining submucosa.
Zoom Image
Fig. 2 Fig. 2 Pathological findings of the resected specimen. Histological photograph of an adenocarcinoma at the esophagogastric junction. Atypical glandular epithelium forms irregular tubules, creating polypoid, protruding lesions. Immunostaining shows a mutant pattern of p53 overaccumulation. Meanwhile, a flatly spreading adenocarcinoma is observed around the protrusions. Submucosal esophageal glands in the columnar epithelium region are identified, suggesting an adenocarcinoma arising in Barrett's esophagus.
Zoom Image
Fig. 3 Fig. 3 The healing process of the post-ESD ulcer. The epithelialization progressed in chronological order from [Fig. 3Fig. 3] a–f. A total of 50 mg or 100 mg of TA was locally injected into the regenerating submucosal layer from [Fig. 3Fig. 3] a–e, respectively. a 1 week after ESD (3rd local injection of TA). b 4 weeks after ESD (6th local injection of TA). c 8 weeks after ESD (10th local injection of TA). d 12 weeks after ESD (14th local injection of TA). e 20 weeks after ESD (22nd local injection of TA). f 40 weeks after ESD. Complete epithelialization without any stricture was achieved, and a φ9.8-mm scope (GIF-H290T; Olympus Medical Systems, Tokyo, Japan) passed easily.